Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ibrahim B. Dagher Insider Profile
11 Followers
Ibrahim B. Dagher, Chief Medical Officer at Brainstorm Cell Therapeutics, holds 190.00K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Ibrahim B. Dagher Sold $63,000 shares of Brainstorm Cell Therapeutics on Jul 24, 2024 for an estimated value of 22.05K.
Ibrahim B. Dagher has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ibrahim B. Dagher's holdings
Insider Roles
Chief Medical Officer
Roles that Ibrahim B. Dagher holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ibrahim B. Dagher
Ibrahim B. Dagher's Trading History
List of latest transactions for each holding click on a transaction to see Ibrahim B. Dagher's performance on stock
You May Also Like
Ibrahim B. Dagher insider profile FAQ
What is the percentage of profitable transactions made by Ibrahim B. Dagher?
The percentage of profitable transactions made by Ibrahim B. Dagher is ―.
What is the average return per transaction made by Ibrahim B. Dagher?
The average return per transaction made by Ibrahim B. Dagher is ―.
What stocks does Ibrahim B. Dagher hold?
Ibrahim B. Dagher holds: BCLI stocks.
What was Ibrahim B. Dagher’s latest transaction?
Ibrahim B. Dagher latest transaction was an Informative Sell of $22.05K.
What was Ibrahim B. Dagher's most profitable transaction?
Ibrahim B. Dagher’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ibrahim B. Dagher's role in Brainstorm Cell Therapeutics?
Ibrahim B. Dagher's role in Brainstorm Cell Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.